ES2065278A1 - Procedimiento de obtencion enantioselectivo del levobunolol. - Google Patents

Procedimiento de obtencion enantioselectivo del levobunolol.

Info

Publication number
ES2065278A1
ES2065278A1 ES09301422A ES9301422A ES2065278A1 ES 2065278 A1 ES2065278 A1 ES 2065278A1 ES 09301422 A ES09301422 A ES 09301422A ES 9301422 A ES9301422 A ES 9301422A ES 2065278 A1 ES2065278 A1 ES 2065278A1
Authority
ES
Spain
Prior art keywords
preparation
naphthalenone
butylamine
dihydro
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301422A
Other languages
English (en)
Other versions
ES2065278B1 (es
Inventor
Diez Del Corral Alberto Stampa
Garcia Pelayo Camps
Miguel M Carmen Onrubia
Aguilar Carmen Arnalot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medichem SA
Original Assignee
Medichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem SA filed Critical Medichem SA
Priority to ES09301422A priority Critical patent/ES2065278B1/es
Priority to CA002119052A priority patent/CA2119052C/en
Priority to US08/213,945 priority patent/US5426227A/en
Publication of ES2065278A1 publication Critical patent/ES2065278A1/es
Application granted granted Critical
Publication of ES2065278B1 publication Critical patent/ES2065278B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN NUEVO PROCEDIMIENTO DE OBTENCION DEL CONOCIDO AGENTE BLOQUEANTE BETAADRENERGICO LEVOBUNOLOL, INDUSTRIALMENTE VENTAJOSO, QUE NO NECESITA DE LA RESOLUCION DEL BUNOLOL RACEMICO, BASADO EN LA SINTESIS ENANTIOSELECTIVA DE UN INTERMEDIO OXIRANICO Y SU POSTERIOR REACCION CON TERC-BUTILAMINA. EL PROCEDIMIENTO DE LA PRESENTE INVENCION CONSISTE EN HACER REACCIONAR LA 5-HIDROXI-3,4DIHIDRO-1(2H)-NAFTALENONA CON LA R-(-)-EPICLORHIDRINA, EN EL SENO DE UN DISOLVENTE APROTICO EN PRESENCIA DE UNA BASE FUERTE Y A UNA TEMPERATURA SUPERIOR A 90GC, PARA OBTENER, CON UNA PUREZA OPTICA SUPERIOR AL 95%, EL OXIRANO QUIRAL INTERMEDIO (S)-5(2,3-EPOXIPROPOXI)-3,4-DIHIDRO-1(2H)-NAFTALENONA Y, POSTERIORMENTE, HACER REACCIONAR EL OXIRANO QUIRAL INTERMEDIO CON TERC-BUTILAMINA.
ES09301422A 1993-06-24 1993-06-24 Procedimiento de obtencion enantioselectivo del levobunolol. Expired - Fee Related ES2065278B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES09301422A ES2065278B1 (es) 1993-06-24 1993-06-24 Procedimiento de obtencion enantioselectivo del levobunolol.
CA002119052A CA2119052C (en) 1993-06-24 1994-03-15 Enantioselective process for the preparation of levobunolol
US08/213,945 US5426227A (en) 1993-06-24 1994-03-16 Enantioselective process for the preparation of leveobunolol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09301422A ES2065278B1 (es) 1993-06-24 1993-06-24 Procedimiento de obtencion enantioselectivo del levobunolol.

Publications (2)

Publication Number Publication Date
ES2065278A1 true ES2065278A1 (es) 1995-02-01
ES2065278B1 ES2065278B1 (es) 1995-09-01

Family

ID=8282328

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09301422A Expired - Fee Related ES2065278B1 (es) 1993-06-24 1993-06-24 Procedimiento de obtencion enantioselectivo del levobunolol.

Country Status (3)

Country Link
US (1) US5426227A (es)
CA (1) CA2119052C (es)
ES (1) ES2065278B1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964613B2 (en) 2007-02-28 2011-06-21 Asahi Kasei Pharma Corporation Sulfonamide compound
CN109160882B (zh) 2018-08-28 2021-07-09 杭州师范大学 一种盐酸左布诺洛尔的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
ES8500256A1 (es) * 1982-03-16 1984-10-01 Kaken Pharma Co Ltd Un procedimiento para preparar s-2-acetil-7-2,3-epoxipropoxi benzofurano.
EP0435068A2 (en) * 1989-12-27 1991-07-03 Daiso Co., Ltd. Process for producing optically active atenolol and intermediate thereof
JPH04198175A (ja) * 1990-11-28 1992-07-17 Daiso Co Ltd 光学活性アテノロール及びその中間体の製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755071A (fr) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone
US4463176A (en) * 1982-09-13 1984-07-31 Mead Johnson & Company Process for resolution of optical isomers
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
DE4133143A1 (de) * 1991-09-30 1993-04-01 Zentralinstitut Fuer Organisch Diastereomere propranololanaloga mit zwei stereogenen zentren und verfahren zu deren herstellung sowie ihrer verwendung als arzneimittel

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
ES8500256A1 (es) * 1982-03-16 1984-10-01 Kaken Pharma Co Ltd Un procedimiento para preparar s-2-acetil-7-2,3-epoxipropoxi benzofurano.
EP0435068A2 (en) * 1989-12-27 1991-07-03 Daiso Co., Ltd. Process for producing optically active atenolol and intermediate thereof
JPH04198175A (ja) * 1990-11-28 1992-07-17 Daiso Co Ltd 光学活性アテノロール及びその中間体の製法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACT OF JAPAN, Vol. 16, n‘ 528 (C-1001)[5571] 29.10.1992 & JP-A-4198175 (DAISO CO, LTD) 17.7.1992 * Resumen * *

Also Published As

Publication number Publication date
CA2119052A1 (en) 1994-12-25
US5426227A (en) 1995-06-20
CA2119052C (en) 2005-08-30
ES2065278B1 (es) 1995-09-01

Similar Documents

Publication Publication Date Title
Edwards et al. Stereospecific synthesis of secondary amines by the Mitsunobu reaction
KR960022492A (ko) N-보호 아미노산 에스테르로부터 n-보호 아미노산 알파-할로메틸케톤 및 알코올의 제조방법
EP0941986A3 (en) A process for producing dialkanolamines
AU594563B2 (en) 2-phenylhydrazonocyclohexanone oxime derivatives
ES2065278A1 (es) Procedimiento de obtencion enantioselectivo del levobunolol.
NZ505027A (en) Novel process for preparing a ketimine
CA2176500A1 (en) Process for Preparing a Chiral Tetralone
CA2023233A1 (en) Halogenoalkylphenyl-alcohols, ketones and hydrates thereof
TR200001657A2 (tr) Şiral tetralondan sertralin hazırlanan işlem
Kitaori et al. A Pratical Synthesis of Optically Active Atenolol from Chiral Epichlorohydrin
EP0926147A4 (en) METHOD FOR PRODUCING 1,3-DIOXOLAN-4-METHANOL COMPOUNDS
MY118006A (en) Process for the preparation of e-caprolactam
AU575665B2 (en) Synthesis of trifluoroethanol and hexafluroisopropanol
MY111320A (en) Process and antiparasitic intermediates for doramectin
EP0575776B1 (en) A process for the preparation of enantiomers of dropropizine
EP0866068A4 (en) METHOD FOR PRODUCING BENZYL METAL COMPOUNDS AND METHOD FOR PRODUCING 4-PHENYL-1-BUTEN USES THEREOF
CA2013080C (en) Process for the synthesis of the n-methyl-3,4-dimethoxyphenylethylamine
US6060624A (en) Racemization of optically active alkoxyamines
CA2250258A1 (en) Novel tetralone or benzopyranone derivatives and process for producing the same
US4789746A (en) Process for the preparation of the (+)-antipode of (E)-1-cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ene
ES8608470A1 (es) Procedimiento para la preparacion de hidratos de fluoral y de hexafluoracetona puros a partir de hemiacetales
EP0257610A3 (en) Process and intermediates for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives and for the synthesis of bicyclo(4.2.0)octane derivatives
Wang et al. Convenient one‐pot synthesis of functionalized cyclopentene via Sm/TMSCI/t‐BuOH system mediated hydrodimerization cyclization of gem‐diactivated alkene
Yada et al. Selectivities in Reductive Amination of 4-t-Butylcyclohexanone and Related Compounds Catalyzed by Platinum Group Metals
JPS60161927A (ja) ケトンの不斉還元方法

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20110805